Posted by AGORACOM-JC
at 8:16 AM on Monday, February 1st, 2021
Announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan .
Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America .
ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
VANCOUVER, BC , Feb. 1, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create their own mobile phone AR campaigns, is pleased to announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan . Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America . ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
Masa Ishimitsu said “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in Japan . Its simple platform means that organizations can almost instantly start engaging their customers and fans at a time when recovery and renewed market positions are essential. As consumers are slowly returning to stores and sports are coming back, information, offers and simple engagement will need to be more dynamic and shareable.”
Mr. Ishimitsu continued “ImagineAR lets marketing ideas get creative and conversations around brands to escalate, enabling experimentation at value and speed unlike other current AR solutions. AR industry in Japan is still at a very early stage of development and this means potentially a great opportunity for ImagineAR to capture market share. Also, Canada is my second home as I am a graduate of high school and the University in Victoria , B,C.. Having spent over 35 years in the international business, together with my bilingual and bicultural background, I am truly excited to be a part of Imagine AR’s team to develop the business in Japan .”
“Mr. Ishimitsu brings an impressive track record of success with major international companies expanding into Japan ,” said Alen Paul Silverrstieen, CEO and President of Imagine AR. “ImagineAR will continue our aggressive global expansion this year.”
This press release is available on the Company’s AGORACOM Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Posted by AGORACOM-JC
at 7:58 PM on Sunday, January 31st, 2021
Beyond Meat has become an $11 BILLION company by creating products designed to emulate beef. The basis of success has come from delivering the experience meat eaters have come to love (hamburgers, hot dogs, etc.) while also achieving the goal of eating healthier.
TAAT™ Beyond Tobacco™ mimics the experiences of cigarettes without nicotine or tobacco. It is engineered to closely emulate the sensory components of smoking a tobacco cigarette, including tasting and smelling just like tobacco.
E-cigarettes and vaping have failed despite existing for 15 years, driving most smokers back to cigarettes because they only perpetuate the problem of nicotine addiction while delivering a completely different user experience to smokers.
Under the leadership of experienced veterans from the tobacco industry, including and especially Philip Morris International, TAAT™ launched in the United States Just 7 weeks ago and has already received repeat orders from more than 60% of convenience and gas station customers.
How good was this launch?
“Out of all of the tobacco category products I have worked with, TAAT™ is an outlier in terms of the level of demand it has had in its early stages. I have launched dozens of new tobacco brands across Canada as well as in the Caribbean, and while many of the new products were reordered by retailers in their first several weeks on the market, none of them were reordered by anywhere near 60% of stores that initially carried them. …. I have confidence that we could replicate these outcomes both in Ohio and in other markets where we may introduce TAAT™ in the future.” – TAAT Chief Revenue Officer Tim Corkum (former commercialization executive for Philip Morris International)
How big is the market TAAT is going after? Tobacco is used by:
34M adults in America, equating to 215 BILLION cigarettes sold in 2018
1.3 billion people worldwide
… and almost all of them aspire to leave nicotine behind. Beyond Tobacco™ from TAAT is about to give them what they want and, if they succeed, give shareholders “Beyond Belief” returns in the next 2-3 years.
Watch this great interview with CEO Setti Coscarella!
Posted by AGORACOM-JC
at 10:32 AM on Thursday, January 28th, 2021
Tim Daniels / Executive Chairman of AI/ML Innovations Inc. / (CSE:AIML / OTC:FIRZF) explains how the Toronto-based business is focusing on acquiring and furthering Artificial Intelligence and Machine Learning technologies that can address urgent societal needs.
The firm’s key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing A.I. innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure.
AI/ML Highlights:
Recently showcased its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation
Health Gauge aims to penetrate the $245bn global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users
Will do this via its proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platform.
Take a seat and learn more about AI/ML and its ambitious vision for the future.
Posted by AGORACOM-JC
at 9:30 AM on Thursday, January 28th, 2021
Phil Waddington / President and CEO of Molecule Holdings Inc. / (MLCL:CSE) discusses the craft-focused, cannabis beverage production company’s cutting-edge work in the nascent Canadian market.
Boasting a 200,000 square foot production facility based in Ontario, the company has just been given the green light to begin selling its unique line of cannabis-infused beverages throughout Canada, starting in Ontario and Québec.
The company’s recent partnership with Vortex Cannabis Inc. allows Molecule to bring its unique line of cannabis-infused beverage products to market this year, while completing its own sales amendment application.
Molecule Highlights:
Molecule’s recent deal with Vortex Cannabis Inc. allows it to begin selling its unique line of cannabis-infused beverages throughout Canada this year.
Vortex will sell products produced by Molecule to provincial retailers, starting with Ontario and Québec.
Molecule has a 200,000 square foot production facility based in Ontario, offering huge capacity.
The company forecasts 2021 Q1 revenue of $3.5m, 2021 Q2 revenue of $5.8m, and a 2021 Run Rate revenue of $18.5m
An early leap of faith into this emerging industry in 2018 has positioned the company well ahead of the pack now.
“We are excited to move into full scale production and sale,” says CEO Phil Waddington.
Posted by AGORACOM-JC
at 7:47 AM on Thursday, January 28th, 2021
Three-year $150,000 SDK licensing and revenue sharing agreement executed.
Announced the execution of a three-year $150,000 SDK licensing plus revenue sharing agreement to deliver Augmented Reality (“AR”) immersive experiences integrated with the new IMP Event App ( www.touchaprize.com ).
In 2019, IMP successfully delivered an AR Scavenger Hunt for the Greater Milwaukee Auto Show presented by Adamm. IMP recent Auto Show clients include: Greater Milwaukee , Alabama , St. Louis , Hawaii International, Sacramento , Orlando , Tampa and other Motor Trend shows.
VANCOUVER, BC and ERIE, Pa, Jan. 28, 2021 –Imagine AR Inc. (CSE:IP) (OTCQB: IPNFF) (“ImagineAR”) and Interactive Marketing Promotions (“IMP) , are excited to announce the execution of a three-year $150,000 SDK licensing plus revenue sharing agreement to deliver Augmented Reality (“AR”) immersive experiences integrated with the new IMP Event App ( www.touchaprize.com ). In 2019, IMP successfully delivered an AR Scavenger Hunt for the Greater Milwaukee Auto Show presented by Adamm. IMP recent Auto Show clients include: Greater Milwaukee , Alabama , St. Louis , Hawaii International, Sacramento , Orlando , Tampa and other Motor Trend shows.
Using ImagineAR’s licensed AR SDK and cloud-based studio suite, IMP will be delivering immersive AR engagements for manufacturers to consumers attending online virtual and near future in-person automobile shows throughout North America. In addition to on-site and virtual AR Scavenger Hunts, AR will be used to place leading product experts from automobile manufacturers virtually ‘on location’ with the consumer to provide new model information as either an avatar or hologram.
“ImagineAR continues to be the global leader in delivering dynamic mobile augmented reality engagements. By integrating the ImagineAR platform with our IMP app, we are providing automobile shows the most advanced interactive consumer attendee engagement solution and data capture tool,” said Bob Kames, CEO IMP .
Posted by AGORACOM-JC
at 10:31 AM on Wednesday, January 27th, 2021
Agreed to increase the size of the Placement.
The Company will now issue up to 14,706,000 units from the treasury of the Company, at a price of $0.85 per Unit for total gross proceeds of up to approximately $12.5 million (the “ Placement ”).
TORONTO, Jan. 27, 2021 — POET Technologies Inc. (“ POET ” or the “ Company ”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, is pleased to announce that in connection with the private placement (the “ Placement ”) announced by the Company earlier today, the Company and a syndicate of agents led by Cormark Securities Inc., and including IBK Capital Corp. and PI Financial Corp. (collectively, the “ Agents ”), have agreed to increase the size of the Placement. The Company will now issue up to 14,706,000 units (the “ Units ”) from the treasury of the Company, at a price of $0.85 per Unit (the “ Issue Price ”) for total gross proceeds of up to approximately $12.5 million (the “ Placement ”).
In addition, the Company and the Agents have also agreed that the Agents shall have an option (the “ Agents’ Option ”) to purchase up to an additional 2,941,200 Units on the same terms, exercisable up until the time of closing of the Placement, for market stabilization purposes and to cover over-allotments, if any. If the Agents’ Option is exercised in full, an additional approximately $2.5 million will be raised and the aggregate proceeds of the Placement will be up to approximately $15.0 million.
In connection with the Placement, the Company will pay a cash commission to the Agents equal to 6.0% of the aggregate gross proceeds of the Placement and will issue broker warrants equal to 6.0% of the number of Units sold under the Placement, each exercisable to acquire one Common Share at the Issue Price for a period of 24 months from the closing date of the Placement.
Posted by AGORACOM-JC
at 8:35 AM on Tuesday, January 26th, 2021
Announced a brokered private placement led by Cormark Securities Inc. of up to 11.8 million units at a price of $0.85 per Unit, to raise gross proceeds of up to $10.0 million .
Marc Lustig , founder and former Chairman of Origin House has committed to be a lead participant in the Placement.
TORONTO , Jan. 26, 2021 – POET Technologies Inc.(” POET ” or the ” Company “) (TSX Venture: PTK) (OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, is pleased to announce a brokered private placement (the ” Placement “) led by Cormark Securities Inc. (” Cormark “) of up to 11.8 million units (the ” Units “) at a price of $0.85 per Unit, to raise gross proceeds of up to $10.0 million . Marc Lustig , founder and former Chairman of Origin House has committed to be a lead participant in the Placement.
Suresh Venkatesan , Chairman and CEO of POET Technologies commented: “We are extremely pleased to see this investment led by Marc Lustig , a well-known Canadian entrepreneur and investor. We are happy to have Marc as a supporter at this point in POET’s growth plan and the proceeds of this offering will strengthen the Company’s balance sheet while streamlining the Company’s plans to seek an additional listing for its Common Shares on NASDAQ Capital Market.”
Each Unit will consist of one common share of the Company (a ” Common Share(s) “) and one Common Share purchase warrant (a ” Warrant “). Each Warrant will entitle the holder to purchase one additional Common Share at a price of $1.15 per Common Share for a period of 24 months following the closing of the Placement. The Warrants are subject to an accelerated expiry if, following the date that is four months and one day after the date of issuance of the Units and prior to the expiry date of the Warrants, the daily volume weighted average trading price of the Shares exceeds $2.30 for ten consecutive trading days. The Placement price of $0.85 per Unit represents a discount of 5.5% of the VWAP (volume weighted average price) of POET’s Common Shares on the TSX Venture Exchange (” TSXV “) for the 5 trading days ended January 25, 2021 .
Closing of the Placement is subject to receipt of all necessary corporate and regulatory approvals, including the approval of the TSXV. Closing of the Placement is anticipated to occur on or about February 11, 2021.
Posted by AGORACOM-JC
at 8:09 AM on Tuesday, January 26th, 2021
Subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology.
Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions.
January 20, 2021 – AI/ML Innovations Inc. (CNSX :AIML.CN ) (OTC:FIRZF) , a company focused on acquiring and furthering Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that its subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology. Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions. Health Gauge was invited to participate in this study as a result of ICDDR,B’s learning of Health Gauge’s break-through solution in digital pulse and ECG analysis, using simple, affordable, and quality digital signal capture. For this study, Health Gauge’s personal health monitoring solution, including its wearable device, smart phone app, and AI-driven cloud processing platform was used, in conjunction with the support of community-based health service providers.
Conclusion
Studies such as this validate the proof-of-concept of Health Gauge’s products, and show the vast and varied commercial opportunities available within Health Gauge’s bespoke business model. It speaks to the merits and importance of how Health Gauge’s latest generation solutions can help solve important community health problems, in affordable ways, while readily fitting into existing managed care programs – anywhere. Physicians, other healthcare professionals, and individuals can apply and adapt the Health Gauge solution to a number of different health conditions and settings for personal health monitoring and management – showing the larger value of Health Gauge’s device and applications.
Blood pressure related pregnancy maladies are of concern globally, and a leading cause of death amongst pregnant women. Health Gauge’s products have both the ability and opportunity to capitalize on this critical women’s health issue, while providing an invaluable service that has a direct impact on health outcomes.
Background
The study, which commenced in 2019, focused on serving pregnant women who were at risk of developing eclampsia, a hypertension-related significant health risk. Hypertensive disorders of pregnancy (HDP) are extremely dangerous to both the mother and child, and are in fact one of the three leading causes of maternal death worldwide. While hypertension complicates 10% of all pregnancies and is responsible for 14% for all maternal deaths globally, in the developing world it is of even greater concern where mortality rates can be as high as 20%.
Posted by AGORACOM
at 11:33 AM on Monday, January 25th, 2021
(MRBL: CSE) (MRBLF: OTC) (2V0: FSE)
www.mymarble.ca
Why Marble?
Revolutionary fintech company utilizing the power of AI technology to help Canadians manage debt, build credit and budget.
Provides users:
Expert budgeting insights
Consumer proposal-exiting guidance
AI-powered credit boosting intelligence
Financial literacy
Robust B2B and B2C offerings.
A trusted fintech provider for businesses to maximize their customers credit profile.
Servicing a previously underserved subprime Canadian market
Strong Insiders/Management Ownership: 35%
What Exactly Does Marble Do?
‘MyMarble’ offers very specific, personalized financial recommendations about when to pay bills, how to prioritize debt management decisions and offers, tracks and highlights personalized data insights.
‘MyMarble’ through its suite of products offers innovative structured credit product solutions:
The MyMarble Ecosystem obtains leads from a number of tier one Canadian fintech companies which are funnelled accordingly due to a detailed needs analysis.
Did You Know 12 Million Canadians Are Below A Prime Credit Rating?
According to MNP (October 2020) , almost 50% of Canadians are living paycheque to paycheque and based on statistics from Statistics Canada’s Household Sector Credit Market Summary (June 2020), for every dollar of disposable income, Canadians carry a $1.77 of debt. Additionally, Canada is a credit-based economy and financial literacy and good credit score is a major determinant to Financial Inclusion.
What Problem Does That Pose To Individuals Seeking Credit?
The Marble Model
How Marble Acquires and Converts Customers
Benefits of This World Class, AI-Powered Platform:
Expert AI Insights and Real-Time Recommendations
Comprehensive monthly reporting provides expert insights to guide the best course of action to manage budgets effectively
Data-Driven Credit Score Improvement Solution
Marble’s Score-Up AI insights suggests steps which will make the biggest positive impact on credit scores using industry-leading monitoring and point deduction technology.
In a recent Personal Finance Sentiments Survey conducted by Marble, approximately 70% of the respondents commented that they were embarrassed by their credit score, proving a willingness to improve their credit to an acceptable mainstream banking level.
In addition, a similar number of the same respondents identified having over $100 in disposable income each month, confirming Score-Up Lite’s affordability to people that could benefit from it.
Specialist Curated Financial Literacy Platform
The company’s Maestro Financial Literacy education platform has been designed and developed by personal finance experts with decades of experience within the industry.
Sustainable Consumer Proposal Exit solution
One of the only companies in Canada that specializes in exiting consumer proposals in a safe, fair and ethical way.
What Does The Company’s Financial Future Look Like?
Posted by AGORACOM-JC
at 7:55 AM on Monday, January 25th, 2021
Received notice of a positive recommendation by Quebec’s Institut national d’excellence en santé et en services sociaux (“INESSS”) to the Health Minister for the inclusion of its Low Molecular Weight Heparin biosimilar (LMWH), Redesca ™ and Redesca ™ HP, on the list of medications covered by the Régie de l’assurance maladie du Québec (RAMQ) for the prevention and treatment of thromboembolic disorders.
“We are very pleased to have received a positive recommendation by INESSS, a key milestone in the coming commercial launch of Redesca™”, said Steve Saviuk , Valeo’s CEO.
MONTREAL , Jan. 25, 2021 – Valeo Pharma Inc . (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (” Valeo ” or the ” Company “), a Canadian pharmaceutical company, announced today that it has received notice of a positive recommendation by Quebec’s Institut national d’excellence en santé et en services sociaux (“INESSS”) to the Health Minister for the inclusion of its Low Molecular Weight Heparin biosimilar (LMWH), Redesca ™ and Redesca ™ HP, on the list of medications covered by the Régie de l’assurance maladie du Québec (RAMQ) for the prevention and treatment of thromboembolic disorders.
“We are very pleased to have received a positive recommendation by INESSS, a key milestone in the coming commercial launch of Redesca™”, said Steve Saviuk , Valeo’s CEO. “Redesca™ has a long and strong history of safety and efficacy with more than 8 years of proven in-market data internationally. Redesca™ will be available across Canada and Valeo intends to pursue discussions for the inclusion of Redesca on all other provincial formularies. Valeo is planning to launch Redesca™ during the first half of 2021.”
In addition to being used primarily for treating and preventing deep vein thrombosis and pulmonary embolism, LMWHs are also now increasingly used as a first line of defense tool in the fight against Covid-19. The World Health Organization (“WHO”) issued guidance regarding the prophylaxis use of LMWH to help prevent complications in the clinical management of severe acute respiratory infections when novel coronavirus (COVID-19) infection is suspected.
